Efficacy and Safety of ARTRA (Glucosamine Plus Chondroitin Sulfate Combination) in Treatment of Chronic Low Back Pain

NCT01990729 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2013-11-21

No results posted yet for this study

Summary

To study the safety and efficacy of ARTRA (glucosamine chondroitin sulfate) in the treatment of non-specific low-back pain of lumbosacral localization in ambulatory care.

Conditions

  • Low Back Pain

Interventions

DIETARY_SUPPLEMENT

ARTRA

ARTRA (glucosamine and chondroitin sulfate)

Sponsors & Collaborators

  • Unipharm, Inc.

    lead INDUSTRY

Principal Investigators

  • Gurkirpal Singh, MD · Irish Clinical Outcomes in Research and Education

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01990729 on ClinicalTrials.gov